Rationale: Modulation of breathing by hypoxia accommodates variations in oxygen demand and supply during, for example, sleep and ascent to altitude, but the precise molecular mechanisms of this phenomenon remain controversial. Among the genes influenced by natural selection in high-altitude populations is one for the adenosine monophosphate-activated protein kinase (AMPK) a1-catalytic subunit, which governs cell-autonomous adaptations during metabolic stress.
Adenosine monophosphate (AMP)-activated protein kinase (AMPK) is central to the cell-autonomous control of energy supply (1) and comprises a heterotrimer of catalytic a-and regulatory b-and g-subunits, which are ubiquitously expressed throughout eukaryotes. Under metabolic stresses such as hypoxia, binding of AMP to one site on the g-subunit and AMP or adenosine diphosphate (ADP) to another increases AMPK activity by, respectively, allosteric activation and promotion of increased phosphorylation at Thr172 of the a-subunit by liver kinase B1 (2, 3) . Alternatively, calcium calmodulin-dependent kinase kinase-b may activate AMPK in response to increases in cytoplasmic calcium (4) . AMPK switches off anabolic pathways and switches on catabolic pathways (1), thereby compensating for deficits in ATP supply via, for example, mitochondrial oxidative phosphorylation. Regulated O 2 supply is key to the maintenance of oxidative phosphorylation and thus cellular energy status in mammals, not least because of the limited capacity for cellular O 2 storage relative to the extensive reserves of other substrates. It was proposed, therefore, that natural selection may have employed AMPK to coordinate whole-body adjustments in response to O 2 deficits in animals (5) . Consistent with this view, recent studies on high-altitude Andean populations showed that the gene for the AMPK a1-subunit (PRKAA1) has been influenced by natural selection through single-nucleotide polymorphisms (6) . Moreover tissue-specific changes in AMPK expression occur in metabolic syndrome-related disorders that are associated with sleep-disordered breathing (7, 8) .
Ventilatory adjustments are critical to the body's capacity to accommodate variations in O 2 demand and supply during sleep and ascent to altitude. This phenomenon is exemplified by the fact that adaptation of mammals to hypoxia at altitude is initially characterized by progressive increases in ventilatory drive that partially restore arterial PO 2 and protect against apnea (9) . Ventilatory movements are delivered by respiratory central pattern generators (rCPGs) distributed bilaterally in the pons and ventral medulla. These semiautonomous neural networks comprise core circuits of excitatory and inhibitory interneurons that deliver rhythmic patterns of activity (10) and confer a set point about which respiratory rhythm is continuously modulated through the integration of inputs from those central (10, 11) and peripheral (12) chemosensors that monitor O 2 , CO 2 , and pH. It is generally accepted that the carotid bodies represent the primary arterial chemoreceptors (12) and that the acute hypoxic ventilatory response (HVR) is delivered by increased afferent discharge from the carotid bodies to the rCPGs via, in great part, catecholaminergic networks within the caudal brainstem (13, 14) .
The present study demonstrates conclusively that AMPK deficiency attenuates the HVR, and thus precipitates hypoventilation and apnea, by blocking the activation of hypoxia-responsive nuclei within the caudal brainstem (15, 16) , even where carotid body afferent inputs are normal. Some of these results were previously reported in the form of an abstract (17) .
Methods
The experiments in this study were carried out in compliance with the regulations of the U.K. Animals (Scientific Procedures) Act of 1986.
Breeding of Mice, Genotyping, and Single-Cell Polymerase Chain Reactions
Standard approaches were used in the experiments (see Supplementary Methods in the online supplement). All mice studied were between 3 and 12 months of age.
Computational Video Analysis of Thoracic Activity
Thoracic movements were captured by digital camera, and the thoracic motion index was calculated for each successive frame (see Supplementary Methods).
Isolated Carotid Body
The methods used to study single-fiber chemoafferent activity were adapted from those described previously (18) (see Supplementary Methods). Plots of firing frequency versus superfusate PO 2 were fitted by nonlinear regression using Prism software (GraphPad Software, La Jolla, CA).
Plethysmography
Following 10-to 20-minute acclimation under normoxia (air), mice were exposed to hypoxia (12% or 8% O 2 with 0.05% CO 2 , balanced with N 2 ) or hypoxia and hypercapnia (8% O 2 , 5% CO 2 , balanced with N 2 ). Apnea was defined as cessations of breathing greater than the average duration, including an interval, of two successive breaths (500 ms) during normoxia (19) , with a detection threshold of 0.25 mm Hg (SD of noise). Breathing variability was assessed using Poincaré plots and by calculating the SD of interbreath intervals (BB n ) (19) .
At a Glance Commentary
Scientific Knowledge on the Subject: Ventilatory adjustments are critical to the body's capacity to accommodate deficits in oxygen availability during sleep and ascent to altitude. During hypoxia, increased afferent discharge from the carotid bodies to the brainstem delivers increased ventilatory drive, which restores oxygen supply and protects against apnea. The precise molecular mechanisms involved remain unclear. However, natural selection in high-altitude populations has acted on the gene for the a1-catalytic subunit of the adenosine monophosphate-activated protein kinase (AMPK), which governs cell-autonomous adaptations during metabolic stress.
What This Study Adds to the
Field: We demonstrate, for the first time to our knowledge, that AMPK deficiency leads to respiratory depression during hypoxia characterized by hypoventilation and apnea rather than hyperventilation. Moreover, consequent deficits in the drive to breathe during hypoxia arise at the level of the brainstem, even when carotid body afferent input is normal. This identifies AMPK as a potential new target for therapeutic interventions for sleep-disordered breathing associated with metabolic syndrome-related disorders and ascent to altitude.
ORIGINAL ARTICLE Functional Magnetic Resonance Imaging
Mice were anesthetized with 0.8-1.3% isoflurane in air, their body temperature was maintained at 37 8 C, and their breathing frequency was monitored using pressure pad sensors. A 7-Tesla horizontal bore magnetic resonance imaging scanner (Agilent Technologies, Yarnton, UK), equipped with a high-performance gradient insert (12- Bias-corrected (www.slicer.org) structural images were coregistered to a template (www.spmmouse.org) and averaged using SPM8 imaging software (Wellcome Trust Centre for Neuroimaging, University College London, London, UK). Functional data were realigned to mean volumes of each series, spatially normalized (SPM8 coregistration procedures) using each animal's structural scan, and smoothed using a 0.7 3 0.7 3 4-mm full width at half maximum Gaussian filter.
For first-level analysis, see the Supplementary Methods. In second-level (group) analysis, the t-map for contrast (knockout . control) was thresholded at a level of P , 0.005 with a four-voxel cluster threshold (SPM8 imaging software). Between-group differences were analyzed using a region-of-interest tool. For regions with significant group differences, all voxel signals were averaged at each time point (see also Supplementary Methods).
c-Fos Labeling
Mice were subjected to perfusion following a single exposure to hypoxia (8% O 2 ), brain sections incubated in rabbit anti-c-Fos (1:20,000 or 1:100,000; Calbiochem, San Diego, CA) and rat anti-tyrosine hydroxylase (anti-TH; 1:1000; EMD Millipore, Billerica, MA) antibodies diluted in blocking buffer, then in biotinylated horse antirabbit IgG (1:500; Vector Laboratories, Burlingame, CA), and goat antirat IgG (1:750, A594; Invitrogen, Paisley, UK) secondary antibodies (see also Supplementary Methods).
Statistical Analysis
Statistical comparisons were made using GraphPad Prism 6 software for the following: for afferent discharge, singleor two-factor analysis of variance with Bonferroni-Dunn post hoc analysis; and for plethysmography, one-way analysis of variance with Bonferroni multiplecomparisons test. P , 0.05 was considered significant. For functional magnetic resonance imaging (fMRI), a two-sample t test (SPM8) was used with the level of significance set at P , 0.005.
Results

Loss of AMPK Leads to Ventilatory Dysfunction during Hypoxia
Global knockout of both AMPK-a1 and AMPK-a2 is embryonic lethal. We therefore employed conditional deletion of AMPK-a1 and AMPK-a2 subunits using mice in which these genes were flanked by loxP sequences (a1flx/a2flx) (20) . To direct AMPK deletion to carotid body (12) and brainstem (21) catecholaminergic cells, which contribute to ventilatory control during hypoxia, these knockout mice were crossed with mice in which Cre recombinase was targeted via the tyrosine hydroxylase (TH) promoter (22) . Transient developmental expression of TH occurs in disparate cell groups that do not express TH in the adult mouse (22) , including dorsal root ganglion cells, pancreatic islets, a subset of heart wall cells, and a subset of gastrointestinal tract cells, none of which contribute to the acute HVR. Therefore, such conditional AMPK deletion overcomes embryonic lethality and provides greater discrimination with respect to circuit mechanisms. Cellspecific gene deletion was confirmed by single-cell endpoint reverse transcription-polymerase chain reaction and whole-brain quantitative polymerase chain reaction ( Figures 1A and 1B) , and restriction of Cre to TH-positive cells in the adult mouse was verified by viral transfection of a Cre-inducible vector carrying a reporter gene (see Figure E1 in the online supplement).
We found no significant difference between AMPK-a1/AMPK-a2 double knockouts and controls under normoxic conditions with respect to arterial oxygen saturation as measured by pulse oximetry (Sp O 2 ) (see Figure E2) , venous blood gases, venous blood pH (see Table E1 ), weight gain versus age (see Figure E3 ), breathing frequency, tidal volume, or minute ventilation (see Figure E4 ). Nevertheless, AMPK deletion profoundly affected the HVR.
In control mice, hypoxia evoked pronounced hyperventilation characterized by robust increases in minute ventilation ( Figures  1C and 1D ), breathing frequency, and tidal volume (see Figure E5 ). Dual deletion of AMPK-a1 and AMPK-a2 markedly attenuated the HVR in response to 12% (mild hypoxia) ( Figure 1C ) and 8% O 2 (severe hypoxia) ( Figure 1C ), which conferred comparable stimuli in knockouts and controls in terms of the fall in arterial Sp O 2 (see Figure  E2) . Surprisingly, the degree to which the HVR was attenuated increased in a manner directly related to the severity of hypoxia ( Figures 1C and 1D ), suggesting that AMPK offsets respiratory depression during hypoxia.
Depression of the HVR was most severe upon exposure of AMPK-a1/AMPK-a2 double knockouts to 8% O 2 , which highlights the contribution of AMPK to all phases of the response. For controls, the initial augmenting phase, which is generally accepted to result from increased afferent input from the carotid body, peaked at 106 6 10% (z30 s) relative to normoxia. Following subsequent ventilatory depression (roll off, z100 s), minute ventilation declined to 72 6 8% greater than that measured during normoxia, which was maintained for the latter 2-5 minutes of hypoxia (sustained phase). For AMPK-a1/AMPK-a2 double knockouts, minute ventilation during the HVR was markedly attenuated compared with controls, measuring only 36 6 5% relative to normoxia (P , 0.0001) during the augmenting phase before declining to 24 6 5% during the sustained phase (2-5 min; 8% O 2 ) (P , 0.0001). Deficits in minute ventilation resulted from reductions in both breathing frequency and tidal volume (see Figure E5 ). By contrast, marked and comparable increases in minute ventilation were evoked upon exposure of controls and knockouts to hypoxia with hypercapnia (8% O 2 and 5% CO 2 ) ( Figure 1C ). Moreover, in analysis of BB n , we identified greater levels of disordered breathing in AMPK knockouts during hypoxia but not during hypercapnic hypoxia, and the severity of disordered breathing increased in a manner directly related to the degree of hypoxia ( Figures 1D-1G ).
Hypoxia-evoked hypoventilation in AMPK-a1/AMPK-a2 double knockouts was accompanied by frequent, prolonged apneas (<6 s) ( duration was 953 6 40 milliseconds, and apnea duration index (frequency 3 duration) was 13.8 6 2.2, which were significantly greater (P , 0.0001) than measures of apnea frequency (1.8 6 0.3/min), apnea duration (709 6 17 ms), and apnea duration index (1.3 6 0.2) during hyperventilation in controls ( Figures  2DI-2DIII ). As might be expected, given the outcomes for minute ventilation, apnea frequency and duration also increased in a manner directly related to the severity of hypoxia, and these increases were completely reversed during hypercapnic hypoxia ( Figure 2D ). Therefore, AMPK deletion selectively blocks the HVR and thus precipitates hypoventilation and apnea. Furthermore, because hypercapnic ventilatory drive is retained in these mice and is delivered by CO 2 -and/or pHsensitive catecholaminergic neurons (14, 23) , it is evident that AMPK deletion does not simply block neuronal activation or synaptic transmission per se (see also below, AMPK IS NOT REQUIRED FOR CAROTID BODY ACTIVATION BY HYPOXIA).
AMPK Is Not Required for Carotid Body Activation by Hypoxia
Surprisingly, reductions in superfusate PO 2 increased chemoafferent discharge exponentially in all carotid bodies (Figures 3A and 3B), with peak discharge frequency (at PO 2 z74 mm Hg) measuring 12.5 6 1.6 Hz (n = 10) for controls and 13.9 6 1.5 Hz (n = 8; P , 0.001) for AMPK-a1/AMPK-a2 double knockouts. Therefore, AMPK is not required for carotid body activation during hypoxia, and AMPK deletion does not compromise either exocytosis in or subsequent synaptic transmission by THexpressing cells. Hence, AMPK deletion must block the HVR by attenuating activation of the hypoxia-responsive respiratory network at a point distal to the carotid body.
AMPK Deletion Markedly Attenuates Activation of Brainstem Nuclei by Hypoxia
Catecholaminergic and other neurons of the nucleus tractus solitarius (NTS) and ventrolateral medulla receive inputs from the carotid body (21, 24, 25) , are activated by central nervous system hypoxia, and may independently regulate rCPGs in a manner dependent on continued basal (normoxic) afferent input from the carotid bodies (13, 16, 26) . Brainstem activity during hypoxia was therefore assessed by fMRI in anesthetized mice in light of the fact that 9% or less O 2 induces cerebral vasodilation sufficient to eliminate the blood oxygen-level dependent (BOLD) signal driven, under normoxia, by increases in cerebral blood flow in response to sensory stimulation (27) . This allowed analysis of regional differences in signal change resulting from reductions in O 2 consumption (decreased BOLD signal) in AMPK-a1/AMPK-a2 double knockouts relative to controls during acute exposure to 8% O 2 (2 min; z40% Sp O 2 ). In second-level (group) fMRI analysis during hypoxia, we identified significantly different BOLD signals in two well-defined dorsal active regions (DARs) and ventral active regions (VARs) of the caudal brainstem of all AMPK-a1/AMPK-a2 double knockouts compared with controls ( Figures 4C and 4D) . Signal change for the DAR measured 223.58 6 1.17 in controls and 214.93 6 0.91 in AMPK-a1/AMPK-a2 double knockouts (P , 0.01) ( Figure 4E ). Signal change for the VAR measured 211.78 6 0.91 in controls and 28.3 6 0.37 in AMPK-a1/AMPK-a2 double knockouts (P , 0.05). The DAR and VAR exhibited pronounced right-left asymmetry, although removing the four-voxel cluster threshold revealed limited evidence of right side-dominant bilateral symmetry for the VAR alone (see Figure E6 ). Hypoxia (8% O 2 ) evoked concomitant increases in breathing frequency of 16.54 6 12.92 breaths per minute in controls (n = 5) ( Figures 4A and 4B) . By contrast, all AMPK-a1/AMPK-a2 double knockouts exhibited concomitant decreases in breathing frequency of 259.80 6 1.75 breaths per minute (n = 6; P , 0.001) ( Figures 4A and 4B) . Furthermore, anesthesia sufficient to decrease the breathing frequency of AMPK-a1/AMPK-a2 double knockouts less than 90 breaths per minute precipitated irreversible respiratory failure within 30 seconds of hypoxia (n = 4; excluded from fMRI analysis). Therefore, anesthesia exacerbates hypoxic respiratory depression in AMPK-a1/AMPK-a2 double knockouts.
The caudal location relative to the bregma of the DAR ( Figure 4C ) is consistent with that of the NTS, within which poorly defined subgroups of A2 catecholaminergic neurons receive carotid body afferent inputs (24) and are activated during hypoxia (16, 21) . The location of the VAR aligns well with the C1/A1 catecholaminergic neurons of the ventrolateral medulla, which are activated during hypoxia via afferent inputs from both carotid bodies and the NTS (21, 28, 29) . We therefore used immediate early gene expression (c-fos), the only truly physiological approach available (13, 21) , to identify the subpopulations of cells within 5A and 5B). These data suggest differential AMPK dependency of the activation during hypoxia of dorsal and ventral brainstem nuclei known to contribute to the HVR. Although we cannot rule out the possibility of confounding developmental abnormalities associated with AMPK deletion, we observed no deficits in ventilatory function during normoxia or hypercapnic hypoxia, no obvious structural anomaly by fMRI, and no deficit in Figure 4A , lower panel). *P , 0.05; **P , 0.01.
TH-positive or TH-negative cell counts within the brainstem of AMPK-a1/AMPKa2 double knockouts.
Loss of AMPK a1-Subunit Expression Is the Primary Cause of Ventilatory
Dysfunction during Hypoxia Figure 6 shows a comparison of exemplary Poincaré plots of BB n versus subsequent BB n (BB n11 ) during normoxia ( Figure 6AI ) and hypoxia ( Figure 6BI ) for controls and knockouts of AMPK-a2, AMPK-a1, and AMPK-a1/AMPK-a2. During hypoxia, while BB n of AMPK-a2 knockouts were similar to those of controls, breathing irregularities resulted from AMPK-a1 deletion. These irregularities increased in severity with deletion of both AMPK-a1 and AMPK-a2. Confirmation was provided by comparison of the SD of BB n ( Figures  6AII and 6BII ), which increased from 167 6 24 milliseconds during hypoxia with AMPK-a1 deletion to 238 6 23 milliseconds with deletion of both AMPK-a1 and AMPK-a2 (P , 0.001). Likewise, comparison of apnea duration index ( Figure 6C ) and minute ventilation ( Figure 6D ) demonstrated that ventilatory dysfunction was driven primarily by loss of AMPK-a1 but was more severe for AMPK-a1/AMPK-a2 double knockouts. Hence AMPK-a2 containing heterotrimers confer only marginal compensation for loss of AMPK-a1.
Discussion
Deficiencies of AMPK expression precipitated ventilatory dysfunction during hypoxia characterized by marked hypoventilation rather than hyperventilation and frequent, prolonged apneas. Upon hypoxia at altitude or during sleep, AMPK activation may therefore support hyperventilation and ORIGINAL ARTICLE thus protect against hypoxia-induced ventilatory instability (9), while AMPK deficiency may confer greater susceptibility to disordered breathing. That loss of AMPK-a1 was the primary precipitant is notable in this respect, given that natural selection in highaltitude Andean populations has led to single-nucleotide polymorphisms in PRKAA1, the gene for AMPK-a1 (6).
Against expectations, however, AMPK deletion failed to attenuate hypoxia-evoked afferent discharge from the carotid body. This is contrary to our previous pharmacological studies, which suggested that AMPK activation by hypoxia might elicit type I cell exocytosis and increase afferent discharge (18) , but is consistent with more recent investigations (30) . Previous conflicting observations may have arisen due to off-target effects of pharmacological tools, such as aminoimidazole-4-carboxamide-1-b-Dribofuranoside-mediated reductions in the adenylate pool and ATP (20, 31) . Regardless, AMPK is clearly not necessary for carotid body activation by hypoxia. Given that AMPK deletion blocked the HVR, this may appear contrary to the view that increased afferent discharge from the carotid body to the brainstem determines the ventilatory response to a fall in arterial PO 2 (12) . However, evidence suggests that the HVR is determined by the coordinated action of the carotid body and a hypoxiaresponsive circuit within the brainstem (26) comprising, in great part, TH-expressing catecholaminergic cells (14, 15) .
Consistent with this view, in fMRI analysis, we identified that AMPK deletion markedly attenuated activation by hypoxia of dorsal and ventral nuclei of the caudal brainstem, even though carotid body afferent discharge was retained, and this was corroborated by our analysis of c-fos expression. The caudal location relative to the bregma of the DAR is consistent with areas of the NTS that are activated by hypoxia and which represent the primary site of receipt of carotid body afferent input (13, 16, 24) . Here AMPK deletion selectively attenuated c-fos expression during hypoxia by mixed subpopulations of C2 neurons and A2 neurons (SubP, SolM) within the SolM proximal to the midline and the SubP, which are activated during hypoxia (21) . A2 neurons of the NTS provide afferent input to and determine, together with the carotid body, activation by hypoxia of A1/C1 neurons within the ventrolateral medulla (21, 28) , the position of which (28) aligns well with the VAR identified by fMRI analysis. By contrast, projections of the NTS mostly avoid (28) the Bötzinger and pre-Bötzinger complexes (32) . AMPK deletion selectively reduced c-fos expression by TH-positive A1 neurons during hypoxia. This may be significant, given that carotid body afferent input alone is sufficient to activate C1 neurons and thus elicits hypotension (29) , which was likewise induced by hypoxia in AMPK knockouts and controls.
Our findings therefore suggest that respiratory input from the carotid chemoreflex may be blocked by loss of AMPK function within a neuronal circuit spanning the C2/A2 neurons of the NTS and the A1 neurons of the ventrolateral medulla, which opposes respiratory depression during hypoxia. This is consistent with optogenetic and pharmacological interventions at the NTS (16, 33) and the proposal that NTS neurons lie on the sensory side of the central respiratory network (34, 35) . Observed right-left asymmetry of brainstem activation during hypoxia (Figure 4 ) may provide for specialization sufficient to prevent delays in respiratory responses to hypoxic stress by limiting conflicting outputs from each side of the brain (36) as for cognitive performance (37) . Furthermore, and despite the fact that cell counts were not biased by considerations on right-left asymmetry of brainstem activation, the observed changes in c-fos expression suggest that AMPK deficiency attenuates the activation by hypoxia of a discrete subpopulation of respiratory neurons within the C2, A2, and A1 nuclei, which may also explain in part the modest deficits in c-fos expression of AMPK knockouts relative to the ventilatory dysfunction observed. In this respect, it is notable that C2 and A2 neurons are both catecholaminergic and glutamatergic (34, 38) and that 6-10% of TH-positive C2, A2, and A1 neurons also express neuronal nitric oxide synthase, which supports the HVR by synthesizing NO (39) and/or S-nitrosothiols (40) and in a manner that may be facilitated by AMPK (41) . However, further investigation is required to determine how right-left asymmetry is orchestrated by AMPK and the complex interplay of those neurotransmitters deployed during hypoxia.
AMPK deletion in catecholaminergic cells may simply lead to the failure of central integration and transduction of peripheral chemoafferent input and consequent failure of the HVR due to the inability of affected neurons to respond appropriately to metabolic stress (42) . However, given that carotid body afferent discharge remains exquisitely sensitive to a fall in PO 2 and that ventilatory responses to hypercapnia remain unaffected even during severe (8%) hypoxia, our data demonstrate that AMPK deletion does not compromise, per se, the capacity during hypoxia for activation of chemosensory catecholaminergic neurons, exocytosis, or effective delivery of increased respiratory drive. This is consistent with the observation that neuronal integrity during hypoxia may be preserved, in part, by AMPK-independent mechanisms (43) that maintain ATP supply by accelerating glycolysis and in a manner supported by mobilization of astrocyte glycogen stores (44) . That being said, we must also consider why (1) the degree of block by AMPK deletion of the HVR increased in a manner directly related to the severity of hypoxia; (2) the HVR can be triggered by central nervous system hypoxia alone, provided that there is continued receipt of basal (normoxic) afferent input from the carotid bodies (26) ; and (3) interference at any point within this circuit abolishes the HVR (e.g., carotid body resection [45] or AMPK deletion). We therefore hypothesize that AMPK signaling pathways support coincidence detection at a point of signal integration within and thus activation of a hypoxia-responsive circuit that encompasses C2/A2 neurons and ventrolateral A1 neurons. We envisage that coincidence detection is delivered by the capacity for AMPK activation by increases in AM(D)P/ATP ratio (1) determined by "local hypoxic stress" within the NTS (decreased ATP supply), which is coupled with "applied metabolic stress" (increased ATP usage) and/or increased cytoplasmic Ca 21 delivered via afferent input from the carotid bodies to the NTS and, in turn, to ventrolateral A1 neurons ( Figure 7) . Afferent input and brainstem hypoxia could thereby determine, each in part, the set point about which AMPK and thus the brainstem respiratory network are activated during hypoxia. Thereafter, AMPKdependent modulation of cellular metabolism (1), ion channels, and thus neuronal firing frequency (46) and/or transmitter release (40, 41) may facilitate efferent output and thereby deliver increased drive to breathe in a manner that may be attenuated or augmented by appropriate regulation of AMPK expression.
It is also noteworthy that AMPKknockout mice not only hypoventilate during hypoxia but also lie down and appear to enter a torpor-like state from which they recover rapidly when returned to normoxia (see Movies E1 and E2). These mice may therefore engage alternative strategies to reduce O 2 consumption and maintain supply, perhaps by entering a hypometabolic state (47) . This would explain the comparable arterial Sp O 2 for controls and AMPK knockouts during hypoxia, despite the attenuated HVR of the latter.
During anesthesia, loss of suprapontine (voluntary) control of ventilation (48) may have exacerbated hypoxic ventilatory depression in AMPK knockouts and perhaps revealed the true extent of deficiencies in brainstem respiratory drive during hypoxia, which in the extreme precipitated death by irreversible respiratory failure. Interestingly, such outcomes are consistent with the effect of anesthesia on patients with sleep apnea (49) . Moreover, the observed respiratory failure could be triggered by exacerbation of the Cushing reflex (13, 50) , although this is elicited only under anesthesia by ischemic hypoxia (z1% O 2 ) and is maintained or enhanced by hypercapnia (13, 50, 51) . By contrast, hypoxic ventilatory depression was evident in conscious AMPK knockouts during mild and severe hypoxia, as were deficits in brainstem activity, and it was reversed rather than exacerbated by hypercapnia. Furthermore, and contrary to the marked increases in blood pressure associated with the Cushing reflex (13, 50) , hypoxic ventilatory depression in AMPK knockouts was associated with a fall in blood pressure equivalent to that of controls (see Figure E7 ) and wild-type mice (52) . Notwithstanding these facts, hypoxia triggers increased blood pressure in both rats (53) and humans (54), and we cannot rule out the possibility that outcomes for blood pressure may reflect species-dependent variations allied to the Cushing reflex (50) .
We conclude that AMPK opposes central respiratory depression during hypoxia and resists hypoventilation and apnea by supporting increases in central respiratory drive, even where carotid body afferent input is normal. Consequently, AMPK deficiency precipitates ventilatory dysfunction during hypoxia. AMPK is therefore key to O 2 and thus energy (ATP) supply to the body as a whole. Moreover, modulation of AMPK activity or expression may afford new therapeutic strategies against hypoventilation and apnea associated, for example, with metabolic syndrome-related disorders and ascent to altitude (7) (8) (9) . n 
